Drug Type Small molecule drug |
Synonyms N-(2,6-diethyphenyl)-8-({4-[4-(dimethylamino)piperidin-1-yl]-2- methoxyphenyl}amino)-1-methyl-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide phosphate |
Target |
Mechanism TTK inhibitors(Dual specificity protein kinase TTK inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationOrphan Drug (US) |
Not Applicable | - | NMS-153 | (ahnqwfsbmb) = aizjiaghhv bzemtmlldx (wgkhmyfpga ) View more | Positive | 28 Oct 2022 |